ZANTAC CANCER LAWSUITS
Have you or your loved ones been diagnosed with cancer after taking Zantac (ranitidine) to treat heartburn or stomach problems? The FDA mandated the makers of Zantac to withdraw the drug from market because of its carcinogenic impurities. Find out if you or your loved ones may be able to participate in a nationwide Zantac lawsuit and potential settlement by calling (202) 643-1110 or Email [email protected] for a free consultation.
On April 1, 2020, the US Food and Drug Administration (FDA) announced that pharmaceutical manufacturers, such as Sanofi, must pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac, from the market immediately and cease sales. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications. The agency has determined that the impurity in some ranitidine products increases over time, particularly when stored at higher than room temperatures. This causes the consumer exposure to unacceptable levels of NDMA carcinogen.
What is Zantac?
Zantac is the trade name for Ranitidine, a popular medication that reduces the body’s production of stomach acid. The medication is commonly used to treat and prevent ulcers of the stomach and intestines as well as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, peptic ulcer disease, acid indigestion, and heartburn.
Zantac is available both over-the-counter and by prescription. Ranitidine belongs to h2 (histamine-2) blockers class of drugs. OTC Zantac is most commonly used to relieve and prevent heartburn, while the prescription-strength drug is used to prevent more serious ulcers and conditions. The drug came into commercial use in 1981 and is now the 50th most prescribed medication in the United States.
What is NDMA?
NDMA is a probable human carcinogen (a substance that could cause cancer). The World Health Organization has classified NDMA as a potent carcinogen in animal studies (https://www.who.int/water_sanitation_health/dwq/chemicals/ndmasummary_2ndadd.pdf ), the EPA, and the International Agency for Research on Cancer (IARC) has classified NDMA as a probable carcinogen in humans . According to United States National Institutes of Health, NDMA is a volatile, combustible, yellow, oily liquid nitrosamine with a faint characteristic odor that decomposes when exposed to light and emits toxic fumes of nitrogen oxides when heated to decomposition. NDMA is primarily used in laboratory research to induce tumors in experimental animals.
FDA announced on April 1, 2020 that new FDA testing and evaluation prompted by information from third-party laboratories confirmed that NDMA levels increase in ranitidine even under normal storage conditions, and NDMA has been found to increase significantly in samples stored at higher temperatures, including temperatures the product may be exposed to during distribution and handling by consumers. The testing also showed that the older a ranitidine product is, or the longer the length of time since it was manufactured, the greater the level of NDMA. These conditions may raise the level of NDMA in the ranitidine product above the acceptable daily intake limit.
Filing a Zantac Lawsuit
Lawsuits have been filed alleging that Zantac users have been exposed to unsafe levels of cancer-causing NDMA. If you took Zantac and have been diagnosed with cancer, we will work to seek the following damages for you:
- Medical expenses resulting from injuries
- Pain and suffering, both physical and mental, caused by the injuries, treatment, and recovery period
- Wage loss, loss of earning capacity
- Loss of enjoyment of life resulting from damages
- Punitive Damages
- Wrongful Death
Contact us if you have taken Zantac or similar medications and are diagnosed with a serious injury such as:
- Stomach Cancer
- Colon Cancer
- Pancreatic Cancer
- Small Intestine Cancer
- Esophagus Cancer
- Bladder Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other Digestive Tract Cancer
- Death following cancer diagnosis
Oliver-Zhang law is the premier drug product liability law firm that is dedicated to the compassionate representation of Zantac victims and their families. We have the experience of success in recovering just compensation for personal injuries caused by defective products. The amount of time you have to bring a lawsuit or a claim varies from state to state once you discover you have been injured. Delays in filing and missing the statute of limitation can bar your recovery. In Maryland State, Washington D.C. and Washington State, for example, the time to file a personal injury lawsuit due to exposure to a toxic drug is typically three years from the date you discover the cause of your injury. In the Commonwealth of Virginia, the time to file is shorter, only two years. In wrongful death cases, the time to file requirement is even more stringent. We represent Zantac victims nationwide and we can assist you in evaluating whether you have an actionable Zantac claim with a good chance of recovery by litigation or settlement.
Our services are based on contingency fees, so we never charge our clients a dime until they have received compensation first. Contact Oliver-Zhang Law today to find out how we can serve and protect you and your loved ones. Please call (202) 643-1110 or Email [email protected] for a free consultation.